Weill Cancer Hub East launches to transform treatment
The initiative was launched with a $50m gift from the Weill Family Foundation.
The Weill Cancer Hub East brings together experts from the four institutions to improve immunotherapy, a therapeutic strategy that uses a patient's immune cells for treatment.
It aims to drive cross-field partnerships, combining cancer biology, immunology, trials, metabolism and nutrition experts.
With philanthropy from each partner institution, total funding will exceed $125m.
Up to 2034, the hub will explore the connection between solid tumours and their environment.
It also aims to understand how diet and beneficial microbes that help metabolise food can influence cancer treatment effectiveness.
The initiative will investigate how emerging therapeutics such as glucagon-like peptide-1 (GLP-1) agonists are used in diabetes and anti-obesity treatments, which may affect cancer progression and treatment.
The Weill Cancer Hub East will leverage metabolomics, computational analysis, immunology and AI to study how metabolism impacts the immune system's cancer-controlling ability.
It will provide seed funding for collaborative projects focusing on reprogramming the tumour microenvironment and augmenting cell function through patients' metabolisms and microbiomes.
The hub will provide a portfolio of trials, including assessment of the GLP-1 agonist effects on cancer subjects' immune responses and results.
The outcomes may also apply to metabolic, autoimmune and cardiovascular conditions.
The Ludwig Institute for Cancer Research, a cancer research sponsor, is funding studies in cancer metabolism and immunotherapy, providing additional support to the hub's efforts.
A scientific steering committee, with leaders from each academic institution, will oversee the hub's activities.
The scientific strategy of the hub will be directed by a leadership committee, including representatives from partner institutions and the Weill Family Foundation.
The adaptable structure of the hub will allow it to respond to upcoming directions in cancer research.
The hub is the second collaborative entity established by the Weill family and the Weill Family Foundation through their philanthropy.
Weill Family Foundation founder and Weill Cornell Medicine Board of Fellows chair emeritus Sandy Weill stated: 'The Weill Cancer Hub East will offer doctors and scientists a tremendous opportunity to revolutionise the treatment of cancer, a disease that complicates so many lives.'
"Weill Cancer Hub East launches to transform treatment" was originally created and published by Pharmaceutical Technology, a GlobalData owned brand.
The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Epoch Times
2 hours ago
- Epoch Times
Nature's First Aid: How Herbs Speed Up Fracture Healing and Soothe Pain
While crossing the street in laced-up heels, Erica Kuo—a certified clinical aromatherapist and herbal aromatherapy educator—tripped when one of her laces came loose. Acting quickly, she reached into her bag and applied arnica cream, an herbal salve she always carries for emergencies. A hospital visit later confirmed a fractured toe, and a fixation device was used to stabilize it. During the three-month recovery period, Kuo relied on herbal teas, botanical oils, and creams, which she applied directly to the injury, to relieve swelling and pain while supporting her body's natural healing process. Natural remedies, Kuo noted in an episode on Health 1+1, can effectively aid recovery and provide relief, alleviating the need for conventional painkillers.
Business Insider
9 hours ago
- Business Insider
Gym bros are taking these 'natural' injections to build muscle
Hello! I'm Mia de Graaf. I run health coverage at Business Insider, and I'm stepping in for Joi-Marie this week while she's on vacation. Physically, I will be at home in New York City this summer. Mentally? Not so. This weekend, I am attempting to transport myself from my kitchen to Florence, Italy, with a zesty homemade agnolotti. Garlic, chiles, dill, and lime? Sign me up. On the agenda: Colonoscopies aren't fun. These new at-home colon cancer screenings offer a shortcut. Eight successful women in different industries told BI how they start their days. Here's one trick to escape huge crowds in Japan during peak season. Moms love this Yeti tote bag — and it's catching Wall Street's attention. But first: Let's check in on gym bros. If this was forwarded to you, sign up here. Download Business Insider's app here. This week's dispatch Hot peptide summer Earlier this week, I fell down a truly epic TikTok rabbit hole. It started with one video: a guy with cartoonish muscles bulging out of a tank top, sitting at his kitchen counter with six vials and a syringe. "It's time for me to get back in shape," he said. "So this is my new peptide stack." A whole hour later, I was deep in the bro wellness multiverse, where peptides rule. Peptides are short-chain amino acids, the building blocks of protein. In theory, you can use different peptides to stimulate different hormones for all kinds of results. You may have heard of peptide serums promising to boost collagen in your cheeks, or the weight-loss drug Ozempic, a peptide that suppresses hunger. Then, there are peptide shots that you can inject for muscle growth. The chiseled men on my phone screen told me that the idea is to "stack" various peptide shots because each one has slightly different effects. One may stimulate lean muscle, or melt fat for muscle definition, or heal your gym injuries, or slow aging. They rattled off laundry lists of technical names: BPC-157, CJC-1295, ipamorelin, follastatin 344, IGF-1… it goes on. There is a catch. As my colleague Hilary Brueck reports, the science behind muscle-building peptides is scant. Still, the trend is booming. Doctors say they are increasingly fielding questions from patients about which peptides they should use to retain muscle mass. The Vitamin Shoppe has seen a huge uptick in searches for peptides. Why? We're in our "natural gains" era. These days, quiet glow-ups are the hottest thing in cosmetic surgery. Similarly, drugs like steroids, which replace growth hormones, are seen as old-fashioned and toxic. Peptides stimulate your body's natural processes, so they're seen as more natural. This summer, beach bods are in — with a little help from a fridge full of syringes. Check your risk (at home) Colon cancer is the second-deadliest cancer in the US, in large part because people aren't getting their colon checked often enough. While colonoscopies are the most reliable tool, a new suite of at-home tests is rapidly expanding. One recently approved screening tool checks your blood for signs that something is awry. Another highly anticipated test, which isn't out yet, may require nothing more than your breath. Four colonoscopy alternatives. She wakes up like this There's no one-size-fits-all approach to optimizing your morning routine. However, there are a lot of options to try out and many recipes for success. BI spoke to eight successful women across different industries, from professional dancers to bankers and CEOs. Most said they wake up around 6 a.m., but their routines diverge from there. Some hit the gym, while others do affirmations. Also read: Seven men told us how they start their days. Fancy alarm clocks and morning runs are key to their success. Sakura season, without the crowds BI's Anneta Konstantinides visited Japan for its famed cherry blossom season in March, right as the country was experiencing record tourism. While the most popular attractions in Tokyo and Kyoto felt crowded, Konstantinides quickly figured out an easy, affordable, and crowd-free way to enjoy the sights in peak bloom. The secret was in Japan's gardens. The holy grail mom bag The Yeti Camino 35 Caryall Tote Bag has a chokehold on moms on TikTok. They tout it as the sleekest, most durable bag for carrying an array of items while also ferrying their children from place to place. It's even got Wall Street's attention. In a recent note, Jefferies analysts said the Camino 35's virality is boosting confidence in Yeti Holdings' stock. Check it out. What we're watching this weekend "Happy Gilmore 2": Nearly three decades after Adam Sandler's comedy about an unlikely golf hero hit theaters, the comedian's star-studded sequel is coming to Netflix. "The Phoenician Scheme": Wes Anderson's latest film, a surprisingly comedic crime caper starring Benicio del Toro, makes its streaming debut on Peacock. "Hitmakers": Netflix's new reality docuseries about the glamorously cutthroat world of professional songwriting is an entertaining peek behind the curtain at how some of your favorite pop songs get made. What to shop New Yorker must-haves: Discover editor Gabrielle Chase's guide to NYC essentials — packed with smart recommendations on what to pack, where to shop, and how to blend in like a local. One ring to track it all: We put the Oura Ring 4 to the test. It packs powerful health tracking into a sleek, screen-free design. It's discreet, durable, and lasts a week on a charge, but its high price keeps it in luxury territory. Small desk, big upgrade: This sit‑stand desk blends space‑saving design with effortless electric height adjustment — perfect for tight spaces. We tried it, and loved its customizable finishes, sleek design, and smart features. More of this week's top reads: The hidden dilemma of Ozempic: eating disorder recovery. Drew Brees says he's a "very common-sense dieter." Here are five simple wellness rules he lives by. Seven things you should never do when traveling by train, according to an etiquette coach. I've lived in the Hamptons for most of my life. Here are five mistakes I see visitors make every summer. The Coldplay "kiss cam" situation underlines a lesson I learned as a 15-year-old cheerleader. I went to a medical clinic in Portugal — thousands of miles from my NYC home. I saved $500 and found an answer for my back pain. I was born and raised in Italy. There are seven things I wish tourists would stop doing when they come here. The millennial case against having baby number three.
Los Angeles Times
21 hours ago
- Los Angeles Times
Lawmakers press FDA to target knockoff weight-loss drug
Dozens of lawmakers are urging US health regulators to crack down on the booming market for knockoff weight-loss drugs amid mounting concerns over their potential safety risks. On Friday, a group of more than 80 bipartis an lawmakers asked the US Food and Drug Administration to stop counterfeit and copycat versions of GLP-1 drugs like Wegovy and Zepbound from flooding the market — a problem that emerged over the last year. 'We are concerned about recent reports revealing a surge in illegal and counterfeit anti-obesity medications,' they wrote in a letter to FDA Commissioner Marty Makary. 'Undoubtedly, illegal counterfeit medications pose an increased risk to patient safety with sometimes fatal consequences.' The group — spearheaded by Representatives Richard Hudson of North Carolina and Herb Conaway of New Jersey — asked the agency to ramp up enforcement over illegally imported weight-loss drugs. They suggested issuing warning letters and better monitoring non-compliant online retailers and so-called compounding pharmacies that sell the medicines. The lawmakers also said the FDA should work in tandem with US Customs and Border Patrol agents to stop Chinese entities from shipping unsafe weight-loss drugs into the US. They requested an update on the FDA's efforts by July 30, given the 'urgency' of the situation. A spokesperson for the FDA said the agency will work with the US Department of Health and Human Services to provide a 'complete and thorough' response to the issues raised in the lawmakers' letter. 'Any effort to undermine America's supply of safe medicines is an issue that FDA takes seriously,' the spokesperson said. 'And we are deeply committed to strengthening the oversight of imported products at US ports of entry.' In recent years, the popularity of GLP-1 drugs has led to an explosion of copycats and counterfeits made by companies seeking to capitalize on the hype. State-licensed pharmacies were temporarily allowed to make copies of the drugs during a supply shortage, but are no longer permitted to do so after Novo Nordisk A/S and Eli Lilly & Co. boosted production. Still, some pharmacies have refused to wind down their operations while others have pivoted to selling the drugs in lower doses in order to avoid regulatory scrutiny. Counterfeit drugs are made by unregistered entities typically using illegally imported ingredients. As recently as April, there continue to be instances when counterfeit Ozempic pens covertly enter the drug supply chain undetected. Some patients are also purchasing ingredients directly from online sellers in an attempt to make the drugs themselves at home. In both cases, the medications don't go through the same rigorous approval process as brand-name drugs made by Novo and Lilly. Experts worry the lack of oversight is putting patients at risk. The FDA has said it's aware of hospitalizations potentially linked to the copycat drugs, but that adverse events are likely being underreported. 'We support the bi-partisan call for the FDA to crack down on counterfeit and illegally sold weight-loss drugs,' said a spokesperson for Hims & Hers Health Inc., one of the telehealth firms that sells compounded GLP-1s. 'We appreciate lawmakers' recognition that legitimate compounded medications dispensed by state-regulated pharmacies are not counterfeit. Patient safety must always come first.' Novo and Lilly have discouraged consumers from using compounded and counterfeit products, including suing telehealth firms that sell the copycat versions and working with border agents to seize illegal shipments. Under the Biden administration, the companies repeatedly urged the FDA to take action, but the agency mostly limited its actions to issuing consumer warnings — even as its top drug official publicly acknowledged safety concerns. Under the Trump administration, the HHS has also focused more heavily on other issues, such as banning food dyes and examining vaccine schedules. Meanwhile, lawmakers are ramping up their calls for action. State attorneys and other lawmakers have sent letters to the FDA and Federal Trade Commission advocating for greater transparency around the treatments and more scrutiny around marketing practices. Muller writes for Bloomberg.
